`

Stoke Therapeutics

Biotechnology Research

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$36.55M
Total Funding
--
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Stoke Therapeutics

What does Stoke therapeutics do?+

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an entirely new approach to treating severe diseases. We are initially focused on diseases of the central nervous system and the eye, with an emphasis on haploinsufficiencies, which are diseases caused by a loss of about half of the normal protein function. Rather than replace, repair or edit faulty genes, we aim to increase or stoke protein output from healthy genes to restore functional protein levels using our proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform. In all,...

What is Stoke therapeutics's industry? +

Stoke therapeutics operates in the Biotechnology research industry.

What is Stoke therapeutics's revenue? +

Stoke therapeutics's revenue is $36.55m

What is Stoke therapeutics's company size? +

Stoke therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free